Passaic Park, NJ, United States of America

Alvin Seth Stern


Average Co-Inventor Count = 1.8

ph-index = 4

Forward Citations = 120(Granted Patents)


Company Filing History:


Years Active: 1984-2012

Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovations of Alvin Seth Stern

Introduction

Alvin Seth Stern, an accomplished inventor based in Passaic Park, NJ, has made significant contributions to the field of biotechnology. With a total of six patents to his name, his work primarily focuses on the development of cytokine proteins, which play vital roles in immune response and therapeutic applications.

Latest Patents

Stern’s latest invention revolves around the purification and characterization of a cytokine protein known as Interleukin-12 (IL-12), also referred to as Cytotoxic Lymphocyte Maturation Factor (CLMF). This novel protein is synthesized by human NC-37 B lymphoblastoid cells and has shown promising capabilities in the medical field. Specifically, CLMF synergistically enhances the cytolytic activity of Lymphokine Activated Killer (LAK) cells when combined with low concentrations of IL-2. Furthermore, this cytokine is instrumental in stimulating T-cell growth. The patent also encompasses the cloned gene for CLMF, its recombination in a suitable vector, transformed cells containing said vector, the recombinant protein produced by the transformed cells, and antibodies to CLMF.

Career Highlights

Alvin Seth Stern has aligned his research efforts with Hoffmann-La Roche Inc., a prominent firm known for its extensive work in pharmaceuticals and biotechnology. His contributions within this esteemed company have greatly advanced the understanding and utilization of cytokine proteins in clinical settings.

Collaborations

Throughout his career, Stern has collaborated with notable colleagues, including Maurice Kent Gately and Ulrich Andreas Gubler. These partnerships have fostered a dynamic exchange of ideas and innovations, leading to groundbreaking advancements in their respective fields.

Conclusion

Alvin Seth Stern's dedication to innovation and his successful patents, particularly in the area of cytokine proteins, underscore his impact on the biotechnology landscape. His work not only enhances the scientific community's understanding of immune response but also paves the way for potential therapeutic advancements in treating various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…